Loring Wolcott & Coolidge Fiduciary Advisors’s GE HealthCare GEHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $115K | Sell |
1,552
-6
| -0.4% | -$444 | ﹤0.01% | 333 |
|
2025
Q1 | $101K | Sell |
1,558
-902
| -37% | -$58.5K | ﹤0.01% | 330 |
|
2024
Q4 | $219K | Sell |
2,460
-140
| -5% | -$12.5K | ﹤0.01% | 275 |
|
2024
Q3 | $231K | Sell |
2,600
-62
| -2% | -$5.51K | ﹤0.01% | 270 |
|
2024
Q2 | $220K | Buy |
2,662
+52
| +2% | +$4.3K | ﹤0.01% | 263 |
|
2024
Q1 | $220K | Sell |
2,610
-300
| -10% | -$25.3K | ﹤0.01% | 265 |
|
2023
Q4 | $213K | Sell |
2,910
-450
| -13% | -$33K | ﹤0.01% | 274 |
|
2023
Q3 | $233K | Sell |
3,360
-1,963
| -37% | -$136K | ﹤0.01% | 267 |
|
2023
Q2 | $432K | Buy |
+5,323
| New | +$432K | ﹤0.01% | 222 |
|